75mg Braftovi Encorafenib Pharmaceutical Capsules
₹ 5,000 /Box
New Delhi


75mg Braftovi Encorafenib Pharmaceutical Capsules are oral kinase inhibitor targeting mutant BRAF (V600E/K), supplied as hard‑gelatin capsules (stylized "A" on beige cap, "LGX 75 mg" on white body), approved for use in combination therapy for melanoma, colorectal cancer (with cetuximab ± mFOLFOX6), and non-small cell lung cancer—each requiring a confirmed BRAF V600 mutation
View export-ready suppliers